The future of skin sensitization testing lies in the integration of multiple testing strategies to form a comprehensive assessment. This may involve using a combination of in vitro, in chemico, and computational methods to predict sensitization potential more accurately. Advances in computational toxicology, such as quantitative structure-activity relationship (QSAR) models, are expected to play a crucial role in this integrated approach.
